TACSTD2 and ovarian cancer: These results obtained with SG confirmed the results of a previous study from our group in which Trop-2 expressing ovarian cancer cell lines were found highly susceptible to ADCC when exposed to the naked humanized anti-Trop-2 monoclonal antibody hRS7 [32].